Gryphon Financial Partners LLC Morpho Sys Ag Transaction History
Gryphon Financial Partners LLC
- $599 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding MOR
# of Institutions
72Shares Held
11.3MCall Options Held
320KPut Options Held
1.1M-
Glazer Capital, LLC New York, NY1.45MShares$27 Million2.74% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.3MShares$24.3 Million0.04% of portfolio
-
Ubs Group Ag1.17MShares$21.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.02MShares$18.9 Million0.0% of portfolio
-
Carlson Capital L P Dallas, TX950KShares$17.7 Million1.45% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Market Cap $2.54B
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...